Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dhanalaksmi Bakthavatsalam
Observed names:
Bakthavatsalam, D,
D Bakthavatsalam,
D. Bakthavatsalam
Observed institutions:
University of Siena,
Edinburgh Royal Infirmary,
North Middlesex University Hospital NHS Trust,
North Middlesex Hospital
OpenAlex ID:
A5091967705
GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
2023
·
Erola Pairo-Castineira
, Konrad Rawlik
, et al.
·
Nature
·
224
PDF
A second update on mapping the human genetic architecture of COVID-19
2023
·
The COVID-19 Host Genetics Initiative
, Leadership
, et al.
·
Nature
·
118
PDF
Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2023
·
O Abani
, A Abbas
, et al.
·
The Lancet Diabetes & Endocrinology
·
41
PDF
Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial
2024
·
Saul N Faust
, Richard Haynes
, et al.
·
The Lancet Child & Adolescent Health
·
39
PDF
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity
2021
·
Chiara Fallerini
, Nicola Picchiotti
, et al.
·
Human Genetics
·
37
PDF
Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
·
12
PDF
Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19
2023
·
Erola Pairo-Castineira
, Konrad Rawlik
, et al.
·
Nature
·
9
PDF
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O. Abani
, A. Abbas
, et al.
·
EClinicalMedicine
·
5
Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2025
·
O Abani
, A Abbas
, et al.
·
The Lancet Infectious Diseases
PDF
Show more works
View as search
Works count:
10
Citation count:
484
H-index:
7
I10-index:
6
Year
Topic
Type